Capozide 50/25 side effects by duration, gender and age - a phase IV clinical study of FDA data


Side effects are reported by people who take Capozide 50/25. Common side effects include anaphylactic reaction among females, and angiotensin ii increased among males.

The phase IV clinical study is created by eHealthMe based on 4 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 02, 2023

4 people who take Capozide 50/25 and have side effects are studied.

What is Capozide 50/25?

Capozide 50/25 has active ingredients of captopril; hydrochlorothiazide. Currently, eHealthMe is studying from 4 Capozide 50/25 users.

Number of Capozide 50/25 reports submitted per year:

Capozide 50/25 side effects.

Capozide 50/25 side effects by gender *:


  1. Anaphylactic reaction (serious allergic reaction)
  2. Tetany (involuntary contraction of muscles)


  1. Angiotensin ii increased
  2. Cough

Capozide 50/25 side effects by age (0-1 to 60+) *:












  1. Tetany (involuntary contraction of muscles)





* Approximation only. Some reports may have incomplete information.

Do you take Capozide 50/25?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on captopril; hydrochlorothiazide (the active ingredients of Capozide 50/25) and Capozide 50/25 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Capozide 50/25:

All Capozide 50/25 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: